References
- Bishop M. P., Gallant D. M., Sykes T. F. Extrapyramidal side effects and therapeutic response. Arch. Gen. Psychiat. 1965; 13: 155–162
- Blair Donald. Modern drugs for the treatment of mental illness. Staples Press. 1963
- Bjørn S, Rasmussen C. Sordinol (Clopenthixol) in the treatment of schizophrenics. Acta Psychiat. Scand. 1963; 39: 427–436
- Demars J.-P. Neuromuscular effects of long-term Phenothiazine Medication, Electroconvulsive theraphy and Leucotomi. Journal of nervous and mental disease 1966; 143: 73–79
- Faurbye A., Rasch P. J., Bender Petersen P., Brandburg G., Pakkenberg H. Neurological symtoms in pharmacotherapy of psychoses. Acta Psychiat. Scand. 1964; 40: 10–27
- Gerle Holmberg B., Lundquist G., Roos G.B.-E. Psychofarmaka, Teoretisk bakgrund och praktisk användning. Leo Hälsingborg. 1967
- Goldman D. The relationship of parkinsonism produced by drugs to psychotic reactions. Recent advances in Biological. Psychiatry vol. IV (Wortis J.) 1962; IV: 147–153
- Gross H., Kaltenbäck E. Flupenthixol (fluanxol) ein neues Neuroleptikum aus der Thiaxanthrenreihe (klinische Erfahrungen bei einem psychiatrischen Krankengut). Acta Psychiat. Scand. 1965; 41: 42–56
- Hirsch S., Hirsch D. Dystonic reactions produced by tranquilizers. American Journal of Psychiatry 1960-61; 117
- Irwin S. Considerations for the pre-clinical evaluation of new psychiatric drugs: A case study with phenothiazine-like tranquilizers. Psychopharmacologia 1966; 9: 259–287
- Lingjaerde Odd. Psykofarmaka, Oslo Tanum 1967. Nord. Med. 1965; 75: 80–81
- Nordlander M. Akut dystoni och dyskinesi vid fentiazinbehandling. Läkartidning 1966; 63(suppl II)44–46
- Paulson G. Phenthiazine Toxicity, Extrapyramidal seizures and oculogyric crisies. Journal of Mental Science 1959; 105